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caffold, anchoring, and adaptor proteins coordinate
the assembly and localization of signaling complexes
providing efﬁciency and speciﬁcity in signal trans-
duction. The PKA, PKC, and protein phosphatase-2B/cal-
cineurin (CaN) scaffold protein A–kinase anchoring protein
(AKAP) 79 is localized to excitatory neuronal synapses
where it is recruited to glutamate receptors by interactions
with membrane-associated guanylate kinase (MAGUK)
scaffold proteins. Anchored PKA and CaN in these complexes
could have important functions in regulating glutamate
receptors in synaptic plasticity. However, direct evidence
for the assembly of complexes containing PKA, CaN,
AKAP79, and MAGUKs in intact cells has not been available.
In this report, we use immunoﬂuorescence and ﬂuorescence
resonance energy transfer (FRET) microscopy to demonstrate
S
 
membrane cytoskeleton–localized assembly of this complex.
Using FRET, we directly observed binding of CaN catalytic A
subunit (CaNA) and PKA-RII subunits to membrane-targeted
AKAP79. We also detected FRET between CaNA and PKA-RII
bound simultaneously to AKAP79 within 50 Å of each
other, thus providing the ﬁrst direct evidence of a ternary
kinase–scaffold–phosphatase complex in living cells. This
ﬁnding of AKAP-mediated PKA and CaN colocalization on
a nanometer scale gives new appreciation to the level of
compartmentalized signal transduction possible within
scaffolds. Finally, we demonstrated AKAP79-regulated
membrane localization of the MAGUK synapse-associated
protein 97 (SAP97), suggesting that AKAP79 functions to
organize even larger signaling complexes.
 
Introduction
 
Recent research advances have shown that molecular associa-
tions regulating subcellular targeting of signaling proteins
are crucial for efficient and specific signal transduction
(Smith and Scott, 2002). At the postsynaptic membrane of
neuronal excitatory synapses, postsynaptic density-95, discs
large, zona occludens-1 (PDZ)* domain–containing scaffold
proteins combine with cytoskeletal proteins in the postsynaptic
density (PSD) (Sheng and Scala, 2001). Organized around
these PSD scaffolds are membrane receptors including
 
N
 
-methyl-
 
D
 
-aspartate (NMDA) and 
 
 
 
-amino-3-hydroxy-
5-methylisoxazole-4-propionic acid (AMPA) ionotropic glu-
tamate receptors as well as intracellular signaling proteins. Im-
portantly, it is believed that regulation of PSD scaffolding is
interrelated with signaling by glutamate receptors in long-
term potentiation (LTP) and long-term depression (LTD)
plasticity linked to learning and memory (Sheng and Lee,
2001; Tomita et al., 2001).
One prototypic signaling scaffold that might have impor-
tant functions in synaptic plasticity is A-kinase anchoring
protein (AKAP) 79 (humanAKAP79/ratAKAP150) (Bregman
et al., 1989; Carr et al., 1992). AKAP79 is a membrane/
cortical cytoskeleton–targeted anchoring protein that binds
the cAMP-dependent protein kinase (PKA) regulatory (R)
subunits, PKC, and protein phosphatase 2B/calcineurin cat-
alytic A subunit (CaNA) (Coghlan et al., 1995; Klauck et
al., 1996; Dell’Acqua et al., 1998; Gomez et al., 2002). In
hippocampal neurons, AKAP79, PKA, and CaN are localized
on postsynaptic dendritic spines with F-actin and PSD-95
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family membrane-associated guanylate kinase (MAGUK)
PDZ scaffolds (Gomez et al., 2002). AKAP79 is recruited to
NMDA and AMPA glutamate receptors at synapses through
binding the MAGUKs PSD-95 and synapse associated pro-
tein 97 (SAP97), respectively, and anchored PKA and CaN
in these complexes participate in the regulation of AMPA re-
ceptor phosphorylation (Rosenmund et al., 1994; Colledge et
al., 2000; Dell’Acqua et al., 2002; Tavalin et al., 2002). Im-
portantly, PKA, CaN, and SAP97 have also been implicated
in the regulation of AMPA receptor activity in LTP and LTD
(Hayashi et al., 2000; Lee et al., 2000; Carroll et al., 2001).
AKAP79 is targeted to the membrane cytoskeleton through
an NH
 
2
 
-terminal basic domain that binds phosphatidylinosi-
tol-4,5-bisphosphate and F-actin (Dell’Acqua et al., 1998;
Gomez et al., 2002). We have recently shown that AKAP79–
PKA synaptic targeting and association with MAGUKs
depends on F-actin and is negatively regulated by NMDA
receptor CaN signaling pathways that also control AMPA
receptors in LTD (Beattie et al., 2000; Ehlers, 2000; Lin et
al., 2000; Gomez et al., 2002). Thus, assembly and disas-
sembly of AKAP79 complexes containing PKA, CaN, and
MAGUKs may be central to synaptic plasticity.
Unfortunately, the biochemical precipitation techniques
used to study the assembly of protein complexes are limited
by steric hindrance from bulky fusion proteins or antibodies,
use of detergents to solubilize complexes from cells, and
poor yield of proteins precipitating through intermediate
proteins. For instance, precipitation studies have shown
limited amounts of CaN and PKA associated together
with  AKAP79 and have been unable to detect CaN and
MAGUKs coprecipitating through the AKAP (Coghlan et
al., 1995; Colledge et al., 2000). Even when biochemical
methods work ideally, they still do not provide information
about the existence or localization of the complex in intact
living cells. Thus, precipitation methods cannot provide a
complete, accurate depiction of the in vivo condition. As a
first step in visualizing AKAP79 function in vivo, we have
used microscopy techniques that allow observation of pro-
tein binding in living cells to provide direct evidence for
membrane cytoskeleton–localized molecular assembly of the
PKA–AKAP79–CaN ternary complex in association with
SAP97. In this work, we have employed both immunofluo-
rescence and fluorescence resonance energy transfer (FRET)
microscopy using proteins tagged with CFP and YFP vari-
ants of GFP to study signaling complex reconstitution in a
model cell line.
 
Results
 
Using GFP as an expression tag to study protein targeting has
become an indispensable tool of modern cell biology (Tsien,
1998). CFP and YFP variants of GFP have been developed
that can be imaged separately in the same cell. In addition,
energy can be transferred from an excited CFP donor to YFP
acceptor through a nonradiative dipole–dipole interaction
called FRET. There is a strong inverse relationship between
FRET and chromophore separation such that CFP–YFP
FRET (CYFRET) occurs only if the two proteins are in very
close proximity (
 
 
 
50 Å) (Fig. 1, A and B). Thus, CYFRET
can be used to measure protein binding in living cells (Tsien,
Figure 1. CFP/YFP FRET microscopy system for studying AKAP79 
protein–protein interactions in living cells. (A) Model showing no 
FRET between A–CFP and B–YFP tagged proteins in the absence of 
binding. (B) CFP to YFP FRET (CYFRET) resulting in increased YFP 
acceptor emission and quenching of CFP donor emission seen when 
A–CFP and B–YFP tagged proteins are bound within 50 Å of each 
other. (C) CFP- and YFP-tagged (1) AKAP79 WT, (2)  PKA, (3)  CaN, 
and (4) (321–360) constructs used for CYFRET imaging of AKAP79 
binding to CFP- and YFP-tagged (D) CaNA  and (E) PKA-RII . (F) (1) 
AKAP18(1–16) and (2) AKAP18(1–16)–AKAP79(321–360) hybrid 
CFP and YFP fusion proteins for CYFRET imaging of CaNA binding. 
AKAP79 anchors the CaNA,B holoenzyme through binding the 
catalytic CaNA subunit (Coghlan et al., 1995; Kashishian et al., 
1998) and anchors the PKA heterotetrameric R2C2 holoenzyme 
through binding a surface created by dimerization of the of NH2 
terminus of the regulatory subunit (RII / ) (Newlon et al., 2001). 
The NH2 and COOH termini of each protein are indicated by N and 
C or numbers starting with 1 at the NH2 terminus. The AKAP79 CaN 
(315–360, pink) and PKA (388–413, red) binding sites are indicated 
as are the AKAP79 (1–153, A, B, and C poly-basic, blue) and AKAP18 
(1–16, NH2-terminal Gly-myristoylated, dual Cys-palmitoylated) 
membrane targeting domains.T
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1998; Miyawaki and Tsien, 2000). However, the majority of
studies in living cells have focused on the regulation of in-
tramolecular FRET for CFP–YFP indicator proteins reported
as a ratio of YFP to CFP emission during CFP excitation.
This ratio is a very sensitive indicator of changes in FRET
because acceptor and donor emission have an inverse rela-
tionship due to CFP quenching upon FRET with YFP
(Miyawaki and Tsien, 2000; Nagai et al., 2000; Zhang et al.,
2001). However, CYFRET ratio images are not useful for
protein–protein interactions in cells with uncertain stoichi-
ometries due to variable CFP and YFP expression in transient
transfections. Recently, a technique using image subtraction,
called micro-FRET, that is not subject to these limitations
has been shown to produce high-resolution sensitized FRET
images showing protein complexes in live cells (Gordon et al.,
1998; Sorkin et al., 2000). Thus, we have chosen to use mi-
cro-FRET to study PKA and CaN anchoring to AKAP79 in
live cells. To independently confirm FRET measured by this
method, we have also performed parallel YFP acceptor pho-
tobleaching measurement of FRET CFP donor quenching in
fixed cells (Miyawaki and Tsien, 2000).
 
Imaging AKAP79 binding to CaN and PKA in living 
cells with CFP/YFP micro-FRET microscopy
 
To facilitate FRET studies of the AKAP79 scaffold, we gen-
erated cDNA expression vectors for CFP and YFP COOH-
terminal fusion proteins of AKAP79 (Fig. 1 C), CaNA
catalytic subunit (Fig. 1 D), and PKA-RII regulatory sub-
unit (Fig. 1 E) for expression in COS7 cells. COS7 cells
do not express endogenous AKAP79 and have thus been
used in transfection studies to reconstitute AKAP79, PKA,
MAGUK, and glutamate receptor complexes, map the
CaNA binding site on AKAP79, and study AKAP79 target-
ing (Colledge et al., 2000; Dell’Acqua et al., 2002; Gomez et
al., 2002). Importantly, previous AKAP79 COS7 transfec-
tion studies are in good agreement with parallel experiments
done in cultured neurons and brain extracts with endoge-
nous proteins. Using micro-FRET subtraction to generate a
corrected FRET (FRET
 
C
 
) image (see Materials and meth-
ods), we first set out to image binding between AKAP79 and
CaNA. In agreement with earlier studies in fixed COS7
cells, expression of AKAP79WT–CFP (Fig. 1 C, 1) with
CaNA–YFP (Fig. 1 D) resulted in targeting of CaN to
plasma membrane ruffles and intracellular vesicles in living
cells where extensive colocalization with the AKAP was seen
(Fig. 2 A, CFP/YFP Overlay). In contrast, in cells coexpress-
ing CaN–YFP with an AKAP79
 
 
 
CaN–CFP (Fig. 1 C, 3)
mutant lacking the CaN binding site (
 
 
 
315–360) (Dell’Ac-
qua et al., 2002), CaN was in the cytoplasm and not with
membrane-targeted AKAP (Fig. 2 A). In cells express-
ing AKAP79WT–CFP and CaNA–YFP, FRET
 
C
 
 (mono-
chrome) was seen at membrane sites where the two proteins
colocalized, but in cells expressing AKAP79
 
 
 
CaN, no
FRET was detected.
Because the amounts of CFP donor and YFP acceptor will
vary from cell to cell in transient transfections and the inten-
sity of energy transfer is related to the number of YFP accep-
tor/CFP donor pairs, we also calculated FRET values from
membrane ruffles and vesicles normalized (FRETN
 
C
 
) to the
amounts of CFP and YFP. Thus, FRETN
 
C
 
 allows compari-
 
son of FRET from multiple cells for a given acceptor–donor
pairing to demonstrate reproducibility (Table I; see Materi-
als and methods). We calculated a FRETN
 
C
 
 value of 2.8 
 
 
 
0.8 (
 
 
 
10
 
 
 
5
 
) for AKAP79WT–CFP and CaNA–YFP. A
FRETN
 
C
 
 value of 1.4 
 
 
 
 0.4 was obtained (not depicted)
when the chromophores were reversed with CaNA–CFP
and AKAP79WT–YFP (Table I). For the AKAP79
 
 
 
CaN
mutant and CaN, lack of FRET is reflected in a negative
FRETN
 
C
 
 value represented in Table I by 
 
 
 
0. Negative
FRETN
 
C
 
 values are obtained when there is no FRET due to
overcorrection for CFP and YFP cross-bleeding built into
the micro-FRET method (Table I; Materials and methods).
Figure 2. CFP/YFP micro-FRET microscopy imaging of AKAP79 
binding to CaN and PKA in living cells. (A) Plasma membrane/cortical 
colocalization (CFP/YFP Overlay) and direct binding (FRET
C) seen 
for CaNA–YFP (green) and AKAP79–CFP WT but not  CaN 
( 315–360) (blue) in live COS7 cells. (B) Plasma membrane/cortical 
colocalization (CFP/YFP Overlay) and direct binding (FRET
C) seen 
for PKA-RII –YFP (green) and AKAP79–CFP WT but not  PKA 
(1–361) (blue) in live COS7 cells. (C) Negative control showing 
no FRET
C for AKAP79–CFP (blue) and AKAP79–YFP (green) that 
colocalize at the plasma membrane (CFP/YFP Overlay) but do not 
bind to each other. (D) Negative control showing no FRET
C for 
AKAP79–CFP (blue) and AKAP18(1–16)–YFP (green) that colocalize 
(CFP/YFP Overlay) but do not bind to each other. Bars,  15  m.T
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The PKA-RII binding site on AKAP79 (388–409) (Carr
et al., 1992) is even closer to the COOH terminus of the
AKAP than the CaNA binding site (Fig. 1 C, 1), so we next
focused on FRET imaging of AKAP79–PKA binding. In
cells expressing AKAP79WT–CFP (Fig. 1 C, 1), the PKA-
RII–YFP protein (Fig. 1 E) was colocalized with the AKAP
in membrane ruffles and vesicles where FRET
 
C
 
 was also seen
(Fig. 2 B). Accordingly, deletion of the PKA-RII binding
site (
 
 
 
PKA[1–361]; Fig. 1 C, 2) prevented both membrane
targeting of RII and FRET between AKAP79 and RII. Nor-
malized FRETN
 
C
 
 values for multiple cells confirmed repro-
ducible FRET between AKAP79WT–CFP and RII–YFP
(12.1 
 
 
 
 1.1) and the absence of FRET between 
 
 
 
PKA and
RII (
 
 
 
0; Table I). Reversal of the chromophores with PKA-
RII–CFP and AKAP79WT–YFP also produced membrane
FRET
 
C
 
 signals (not depicted) with a similar FRETN
 
C
 
 value
of 13.8 
 
 
 
 3.0 (Table I).
The controls above demonstrating that FRET depends on
CaN and PKA binding to AKAP79 use AKAP deletion mu-
tants that also disrupt CFP/YFP colocalization. Thus, we per-
formed controls confirming that image subtraction was mea-
suring FRET and not colocalized CFP/YFP bleedthrough.
We coexpressed AKAP79WT–CFP with AKAP79WT–YFP
(Fig. 1 C, 1) or a construct fusing YFP onto the COOH ter-
minus of the membrane-targeting domain of the unrelated
AKAP18 (AKAP18[1–16]–YFP; Fig. 1 F, 1) (Trotter et al.,
1999). The CFP/YFP overlay images for cells expressing these
protein pairs revealed significant colocalization of AKAP79–
CFP with AKAP79–YFP (Fig. 2 C) or AKAP18–YFP (Fig. 2
D) at the membrane. However, no FRET
 
C
 
 was detected for
these pairings despite membrane overlap (Fig. 2, C and D).
Negative FRETN
 
C
 
 values (
 
 
 
0; Table I) calculated from mul-
tiple images confirmed a lack of AKAP79 intermolecular
FRET with itself or AKAP18. In contrast to AKAP79,
AKAP18–YFP also showed very strong localization to intra-
cellular perinuclear/Golgi membranes (Fig. 2 D). Impor-
tantly, this strong Golgi YFP signal did not bleed into the
FRET
 
C
 
 image, further confirming the accuracy of image sub-
traction.
 
Confirmation of AKAP79 binding and FRET 
with CaN and PKA in fixed cells using 
YFP acceptor photobleaching
 
The advantage of the micro-FRET method is that it gener-
ates high-resolution, real-time images of sensitized FRET
emission even if the protein–protein interaction is unregu-
lated. However, it is an indirect FRET measurement that
relies on controls done in separate cells expressing donor or
acceptor alone. FRET can also be directly measured within
a single cell by determining the amount of CFP donor
quenching that is relieved by YFP acceptor photobleach-
ing (CFP
 
postbleach
 
 
 
 
 
 CFP
 
prebleach
 
 
 
 
 
 
 
 
 
CFP) and can be ex-
pressed as an apparent donor FRET efficiency percentage
(%
 
 
 
CFP/CFP
 
postbleach
 
). Unfortunately, this photobleaching
method is not suitable for use in our live cell system be-
cause membrane ruffles and vesicles change shape and lo-
cation during the 2 min required to bleach YFP. None-
theless, in fixed cells, we were able to do single cell
comparisons of FRET
 
C
 
 determined by micro-FRET with
apparent FRET efficiency (%
 
 
 
CFP/CFP
 
postbleach
 
) deter-
mined by acceptor photobleaching.
 
Table I. 
 
Normalized FRETN
 
c
 
 for CFP donor and YFP acceptor pairs used to characterize AKAP79, CaNA, and PKA-RII binding interactions 
in live cells
CFP donor YFP acceptor
AKAP79–YFP CaNA–YFP PKA-RII–YFP AKAP18(1–16)–YFP
AKAP79–CFP
 
 
 
0 2.8 
 
 
 
 0.8 12.1 
 
 
 
 1.1
 
 
 
0
 
AKAP79
 
 
 
CaN–CFP
 
  
 
0
 
  
 
AKAP79
 
 
 
PKA–CFP
 
   
 
0
 
 
 
CaNA–CFP
 
1.4 
 
 
 
 0.4
 
    
 
PKA-RII–CFP
 
13.8 
 
 
 
 3.0
 
    
 
AKAP79WT 
 
 
 
 CaNA–CFP
 
  
 
9.1 
 
 
 
 1.6
 
 
 
AKAP79
 
 
 
CaN 
 
 
 
 CaNA–CFP
 
   
 
0
 
 
 
AKAP79
 
 
 
PKA 
 
 
 
 CaN–CFP
 
   
 
0
 
 
 
AKAP79
 
 
 
CaN 
 
 
 
 
 
 
 
PKA 
 
 
 
 CaN–CFP
 
   
 
0
 
 
 
AKAP79(321–360)–CFP
 
 
 
13.3 
 
 
 
 1.0
 
  
 
AKAP18(1–16)AKAP79(321–360)–CFP
 
 
 
35.6 
 
 
 
 10.0
 
  
AKAP18(1–16)–CFP    0   
Mean fluorescence intensities in arbitrary linear units were measured (see Materials and methods) for CFP, YFP, and raw, uncorrected CYFRET for regions
of CFP and YFP overlap in membrane ruffles and vesicles. For each image, corrected FRET
c was calculated from raw CYFRET by fractional subtraction (see
Materials and methods) of CFP and YFP intensity values. The FRET
c intensity values were then normalized (FRETN
c) to the amounts of CFP donor and YFP
acceptor present by the product (CFP)(YFP). FRETN
c is thus proportional to Keq   [donorCFP   acceptorYFP]/[donorCFP][acceptorYFP], the equilibrium
constant for the binding interaction. FRETN
c values are represented above as the mean   SEM ( 10
 5) for multiple images (n   5–8) for each donor–acceptor
pairing. Negative FRET
c values are seen for CFP–YFP pairs that fail to exhibit FRET due to bleedthrough overcorrection (see Materials and methods) that
prevents false positive FRET measurements. Negative FRET pairs are thus represented by FRETN
c values   0 above. Thus, positive FRETN
c values in this table
and the FRET
c images shown in the figures are actually slight underestimates of the actual FRET signals.T
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As in live cells, coexpression of AKAP79–CFP (Fig. 1 C,
1) with CaNA–YFP (Fig. 1 D) or PKA-RII–YFP (Fig. 1 E)
resulted in membrane anchoring of CaN (Fig. 3 A) or RII
(Fig. 3 B) to AKAP79, detected by the micro-FRET
method in fixed cells. AKAP79–CaN and AKAP79–RII
FRET
C signals (pseudo-color) at specific membrane loca-
tions are shown in images gated to the presence of YFP ac-
ceptor (blue underlay) to represent relative FRET intensi-
ties on a scale of blue (no FRET) to green (low FRET) to
red (high FRET) (Fig. 3, A and B, top, second panel from
right). Sites of high relative FRET
C intensity (orange-red)
included vesicles and plasma membrane ruffles where the
donor and acceptors were highly colocalized. Micro-FRET
measurements of FRETN
C in membrane structures for
these fixed samples were very reproducible across multiple
experiments (n    8–12) for AKAP79–CFP paired with
CaN–YFP (14.0   1.2) or RII–YFP (13.0   1.6). This
FRETN
C value for AKAP79–RII in fixed cells is very simi-
lar to that determined in live cells for RII (12.1 and 13.8;
Table I), whereas the FRETN
C value for AKAP79–CaNA
in fixed cells is larger than that determined in live cells for
CaN (1.4 and 2.8; Table I). Thus, quantitative comparison
of FRET for the same protein complex in live cells versus
fixed cells is difficult because fixation may trap the com-
plex in a form with somewhat altered chromophore separa-
tion and orientations compared with in living cells. None-
theless, we can measure FRET
C in fixed cells for AKAP79
binding to PKA and CaN.
Importantly, for both CaN and PKA-RII, selective
bleaching of YFP relieved quenching of AKAP79–CFP do-
nor fluorescence, showing FRET in the same membrane
structures where FRET
C signals were also detected (Fig. 3, A
and B, top, right panels). This dequenching of CFP ( CFP,
pseudo-color) is represented in subtracted images gated to
CFP fluorescence after bleaching (CFPpost, blue underlay) to
once again show relative FRET intensity on a scale of blue
(no FRET) to red (high FRET). Calculation of apparent
FRET efficiency from multiple experiments (n    8–12)
showed that this photobleaching method was also very reli-
able in detecting FRET between AKAP79–CFP and CaN–
YFP (8.4   1.2%) or RII–YFP (5.9   1.2%). Final con-
firmation of the abilities of both the micro-FRET and
photobleaching methods to measure FRET produced by
binding of CaN or PKA to the AKAP scaffold was provided
by analysis of the  PKA (Fig. 1 C, 2) and  CaN (Fig. 1 C,
3) mutants (Fig. 3, A and B, bottom). The corresponding
FRET
C and  CFP images each showed a lack of FRET for
these protein pairings that was confirmed by quantitative
analysis (n    5) showing negative FRETN
C (  0) and
FRET efficiency values ( PKA,   3.5    1.3%;  CaN,
 0.7   0.9%).
Direct binding of CaN to AKAP79 residues 321–360 
detected in living cells by CFP/YFP FRET 
Our findings demonstrate the use of FRET to image bind-
ing between AKAP79 and CaN or PKA in both living and
fixed cells, and from our controls with  CaN and  PKA
mutants, we can infer that these interactions involve the ap-
propriate AKAP binding sites. However, we wished to com-
pliment these “loss of function” controls with a “gain of
function” approach using the AKAP–CaN interaction as an
example. Recently, we demonstrated that residues contained
in 321–360 of AKAP79 can bind CaN in vitro and inhibit
signaling in cells, suggesting that this region is sufficient for
AKAP79–CaN anchoring (Dell’Acqua et al., 2002). To
show that CYFRET observed between AKAP79 and CaN
involves binding between AKAP79 residues 321–360 and
the CaNA subunit, we constructed three additional CFP do-
nors (AKAP79[321–360]–CFP, Fig. 1 C, 4; AKAP18[1–
16]–CFP, Fig. 1 F, 1; and AKAP18[1–16]AKAP79[321–
360]–CFP, Fig. 1 F, 2). In agreement with our previous
studies, expression of the isolated CaN binding domain
(321–360) fused to CFP (Fig. 1 C, 4) produced an untar-
geted protein found in both the cytoplasm and the nucleus
(Fig. 4, A and B). This (321–360)–CFP construct bound to
CaNA–YFP in the cytoplasm and prevented plasma mem-
brane anchoring of CaNA–YFP to AKAP79WT (Texas red
antibody staining) (Fig. 4 A). In parallel live cells, where un-
tagged AKAP79 cannot be seen, colocalization of (321–
360)–CFP and CaNA–YFP and FRET
C were seen exclu-
sively in the cytoplasm (Fig. 4 B). FRETN
C measurements
showed this FRET to be reproducible (13.3   3.0; Table I).
As shown above, the AKAP18 NH2-terminal targeting do-
main (residues 1–16; Fig. 1 F, 1) localizes YFP (Fig. 2 D) or
CFP (Fig. 4 C) to both plasma membrane and, especially,
intracellular Golgi/perinuclear membranes. However, the
Figure 3. Confirmation of micro-FRET detection of AKAP79 binding 
to CaN and PKA by YFP acceptor photobleaching imaging of FRET 
CFP donor quenching in fixed COS7 cells. (A) Membrane colocal-
ization of AKAP79–CFP (blue) and CaNA–YFP (green) with micro-
FRET
C (pseudo-color/gated to YFP [blue underlay]), and relief of 
FRET CFP donor quenching by YFP acceptor photobleaching 
( CFP pseudo-color/gated to CFPpost [blue underlay]) observed for 
AKAP79WT (top) but not  CaN ( 315–360) (bottom). B) Membrane 
colocalization of AKAP79–CFP (blue) and PKA-RII–YFP (green) 
with micro-FRET
C (pseudo-color/gated to YFP [blue underlay]) and 
relief of FRET CFP donor quenching by YFP photobleaching 
( CFP pseudo-color/gated to CFPpost [blue underlay]) observed for 
AKAP79WT (top) but not  PKA (1–361) (bottom). Bars,  15  m.T
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AKAP18(1–16) targeting domain does not bind CaN and
thus cannot target cytoplasmic CaNA–YFP to these loca-
tions (Fig. 4 C, top). The lack of interaction between these
two proteins was confirmed by no detection of FRET
C in
these cells (Fig. 4 C; Table I, FRETN
C   0). In contrast, fu-
sion of the AKAP79 CaN binding region (321–360) onto
AKAP18(1–16) (Fig. 1 F, 2) conferred CaN targeting activ-
ity on AKAP18. Importantly, both CFP/YFP colocaliza-
tion and FRET
C were observed for CaNA–YFP and the
AKAP18(1–16)AKAP79(321–360)–CFP hybrid (Fig. 1 F,
2) in plasma membrane and especially Golgi membranes
(Fig. 4 C, bottom). Measurement of FRETN
C (Table I) re-
vealed this FRET to be reproducible (35.6   10.0). These
findings of FRET with CaNA conferred by AKAP79 resi-
dues 321–360 confirm through a gain of function approach
that our FRET
C images and measurements are truly repre-
sentative of protein binding in live cells.
FRET imaging of the CaN–AKAP79–PKA ternary 
complex in living cells
The identified CaN (321–360) and PKA (388–409) bind-
ing sites on AKAP79 are in very close proximity to each
other in primary sequence (Fig. 1 C, 1). Our FRET mea-
surements above indicate that both proteins bound to
AKAP79 are  50 Å from C/YFP at the AKAP COOH ter-
minus. These findings raise the issue of whether PKA and
CaN are bound to the same AKAP molecule simultaneously
or if there is competition due to steric hindrance between
the closely opposed binding sites. To address this issue, we
sought to reconstitute CaN–AKAP79–PKA ternary com-
plexes in COS7 cells. As a first step, we coexpressed
AKAP79WT–CFP (Fig. 1 C, 1) and PKA-RII–YFP (Fig. 1
E) with myc-tagged CaNA (Dell’Acqua et al., 2002). Cells
were fixed and labeled with anti-myc antibodies to visualize
CaNA along with AKAP79–CFP and RII–YFP. These stud-
ies revealed that AKAP79WT–CFP, PKA-RII–YFP, and
myc–CaNA were all colocalized in plasma membrane ruffles
(Fig. 5 A, top). To show that this colocalization in plasma
membrane structures was due to independent binding of
CaN and PKA to their respective AKAP79 binding sites, we
analyzed the  PKA (Fig. 1 C, 2) and  CaN (Fig. 1 C, 3)
mutants. Deletion of the PKA anchoring site on AKAP79
led to cytoplasmic localization of RII–YFP but retention of
AKAP79–CFP and myc–CaNA at the membrane (Fig. 5 A,
middle). Deletion of the CaN anchoring site on AKAP79
had the opposite effect, causing cytoplasmic localization
of myc–CaNA but maintaining membrane overlap for
AKAP79–CFP and RII–YFP (Fig. 5 A, bottom). These re-
sults do not support a model of competition between PKA
and CaN binding to AKAP79 and suggest that these pro-
teins can bind independently to closely spaced, but func-
tionally separate, binding sites on the AKAP.
Because both proteins bind in close proximity to each other
and exhibit FRET with AKAP COOH-terminal C/YFP, we
reasoned that it might be possible to directly observe the
CaN–AKAP–PKA ternary complex by measuring FRET from
CaNA–CFP to PKA-RII–YFP bound to the same AKAP
molecule. We cotransfected CaNA–CFP, PKA-RII–YFP, and
untagged AKAP79WT into COS7 cells. In agreement with
Fig. 5 A, in cells fixed and antibody stained to visualize
AKAP79WT, colocalization of CaN–CFP, RII–YFP, and
AKAP was seen in membrane ruffles and vesicles (Fig. 5 B). In
parallel live cells (where AKAP cannot be visualized), mem-
brane colocalization of CaN–CFP and RII–YFP was seen in
CFP/YFP overlay images and FRET
C signals were detected at
these sites of overlap (Fig. 5 C, top). A FRETN
C value of
9.1   1.6 (Table I) showed the FRET to be reproducible.
The lack of any significant direct interaction between CaN
and RII that could produce FRET was confirmed by analysis
of untagged AKAP79  CaN and  PKA mutants. In  CaN-
expressing cells, CaNA–CFP was cytoplasmic, RII–YFP tar-
geted to cortical ruffles, and no FRET
C was observed (Fig. 5
C, second row; Table I, FRETN
C   0). In  PKA-expressing
cells, RII–YFP was cytoplasmic, CaNA–CFP targeted to cor-
tical ruffles, and no FRET
C was observed (Fig. 5 C, third row;
Table I, FRETN
C   0). Thus, the membrane colocalization
and FRET seen for CaNA–CFP and RII–YFP in the presence
of AKAP79WT can be attributed to both proteins binding to
Figure 4. Direct observation of CaN binding to AKAP79 residues (321–360) in living cells using CYFRET microscopy. (A) Displacement of 
CaNA–YFP (green) from plasma membrane–targeted AKAP79 (anti-AKAP79, TxRd, red) by an untargeted AKAP79 CaN binding site peptide, 
AKAP79(321–360)–CFP (blue), seen in the RGB composite as red in membrane ruffles and CFP-blue/YFP-green overlap in the cytoplasm. (B) 
Colocalization (CFP/YFP Overlay) and direct binding (FRET
C) seen for CaNA–YFP (green) and AKAP79(321–360)–CFP (blue) in the cytoplasm 
of COS7 cells. (C) The AKAP79(321–360) CaN binding site confers CaNA binding activity on AKAP18 in living cells. Plasma membrane and 
Golgi targeting (CFP/YFP overlay) and direct binding (FRET
C) of CaNA–YFP (green) to AKAP18(1–16)–AKAP79(321–360)–CFP (blue, bottom) 
but not AKAP18(1–16)–CFP (blue, top) in live COS7 cells. Bars,  20  m.T
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AKAP79. This FRET between CaN and PKA-RII in the pres-
ence of AKAP79WT could be due to CaN and PKA binding
separate AKAP molecules clustered in close proximity to one
another. However, we thought that this scenario was unlikely
because coclustered AKAP79–CFP and AKAP79–YFP mole-
cules did not produce detectable FRET (Fig. 2 C; Table I).
Nonetheless, to directly rule out this possibility, we coex-
pressed untagged  CaN and  PKA mutants with CaNA–
CFP and RII–YFP in order to colocalize CaN and PKA in
membrane structures through obligate binding to separate
AKAP molecules. As expected, membrane colocalization of
CaNA–CFP and RII–YFP could be seen in these  CaN  
 PKA–expressing cells, but no FRET was observed (Fig. 5 C,
bottom row; Table I, FRETN
C   0). Proper expression and
membrane targeting of the untagged  PKA and  CaN mu-
tants was confirmed (as in Fig. 5 B) in parallel fixed cells
stained with anti-AKAP79 antibodies (unpublished data).
Thus, detection of FRET between CaNA–CFP and PKA-
RII–YFP in cells expressing AKAP79WT is most consistent
with direct observation of the ternary kinase–AKAP–phos-
phatase complex in living cells.
Plasma membrane targeting and recruitment of SAP97 
to the AKAP79 signaling scaffold
AKAP79 can bind MAGUK scaffold proteins including
SAP97 and PSD-95 (Colledge et al., 2000). In particular,
binding of AKAP79 to SAP97 is believed to recruit AKAP,
PKA, and CaN to GluR1 subunits for the regulation of
AMPA receptor phosphorylation (Colledge et al., 2000;
Dell’Acqua et al., 2002; Tavalin et al., 2002). Using our
transfection system, we set out to characterize the interac-
tion between AKAP79 and SAP97 in living cells. In agree-
ment with previous studies (Tiffany et al., 2000), SAP97–
YFP expressed alone was predominantly cytoplasmic (Fig.
6 A, top). However, expression of SAP97–YFP with
AKAP79–CFP resulted in substantial SAP97 targeting to
membrane ruffles in live cells (Fig. 6 A, bottom). In fixed
cells, these sites of membrane colocalization of SAP97 with
AKAP79 were found to be enriched in cortical F-actin
stained with phalloidin (Fig. 6 B, top). We have previously
shown that the highly-basic NH2 terminus of AKAP79 is
necessary and sufficient for binding to phosphatidylinositol-
4,5-bisphosphate and F-actin in vitro and targeting to den-
dritic spines in neurons and membrane ruffles in COS7 cells
(Fig. 6 E; Dell’Acqua et al., 1998; Gomez et al., 2002).
AKAP79 binds to the SAP97 MAGUK SH3 and GK do-
mains (Fig. 6 F); however, the MAGUK binding site of
AKAP79 is less defined but is thought to be located COOH
terminal to the targeting domain (1–153) and NH2 terminal
to the CaN anchoring site (315–360) (Fig. 6 E; Colledge
et al., 2000). Thus, we expressed SAP97–YFP with
AKAP79(1–153)–CFP as an additional negative control to
support the need for AKAP79–MAGUK binding in SAP97
cortical targeting. As seen previously (Gomez et al., 2002),
Figure 5. Direct observation of a CaN–AKAP79–PKA ternary in living cells using CYFRET imaging. (A) Plasma membrane/cortical targeting 
of CaN and PKA mediated through binding to functionally separable sites on AKAP79. Colocalization of PKA-RII–YFP (green) and CaNA–myc 
with AKAP79WT–CFP (blue) is seen as white in the RGB composite (top). Selective loss of PKA-RII (green) but not CaNA–myc (red) from the 
plasma membrane by deletion of the AKAP79–RII binding site ( PKA), seen as pink in the RGB composite (middle). Selective loss of CaNA–myc 
(red) but not PKA-RII (green) from the plasma membrane by deletion of the AKAP79–CaNA binding site ( CaN), seen as blue-green in the 
RGB composite (bottom). (B) Plasma membrane colocalization of CaNA–CFP (blue), PKA-RII–YFP (green), and untagged AKAP79WT 
(anti-AKAP79, TxRd, red), seen as white in RGB composite. (C) FRET
C measured between CaNA–CFP and PKA-RII–YFP bound to AKAP79WT 
in a ternary complex at the plasma membrane (top). Loss of CaNA–CFP from the AKAP79-RII–YFP complex and loss of FRET
C upon disruption 
of the CaN binding site ( CaN) (second row). Loss of RII–YFP from the AKAP79–CaNA–CFP complex and loss of FRET
C upon disruption of 
the PKA binding site ( PKA) (third row). Membrane colocalization but no FRET
C for CaNA–CFP and RII–YFP targeted through binding to 
separate AKAP molecules ( PKA    CaN) (bottom). Bars,  20  m.T
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AKAP79(1–153)–CFP targeted to membrane ruffles en-
riched with F-actin (Fig. 6 B, middle); however, SAP97–
YFP remained cytoplasmic with little or no colocalization
with cortical actin or the AKAP fragment (Fig. 6 B, bot-
tom). Coexpression of SAP97–YFP with a COOH-terminal
fragment of AKAP79 ([150–427]–CFP) that is unable to lo-
calize to membranes or bind actin (Fig. 6 E; Gomez et al.,
2002) resulted in no targeting of either protein to cortical
actin (Fig. 6 B, bottom). This confirmed that binding of
SAP97 to determinants found COOH terminal to the
AKAP targeting domain must be required for SAP97 target-
ing to membrane ruffles with AKAP79 (Fig. 6 E).
Unfortunately, our efforts to measure FRET between
AKAP79–CFP and SAP97–YFP as well as a chromophore-
reversed pair were unsuccessful (FRET
C images not de-
picted). It is possible that the chromophore separation
distances are too great (i.e.,  50 Å) or chromophore ori-
entations in the complex are not favorable for FRET. De-
spite this lack of FRET between AKAP79 and SAP97, we
combined CFP/YFP imaging with immunofluorescence to
examine membrane-localized assembly of higher-order signal-
ing complexes. Under conditions where we can measure FRET
between AKAP79–CFP and CaN–YFP (Fig. 2 A; Fig. 3 A),
we also detected cortical colocalization of the AKAP and
CaN with myc-tagged SAP97 (Fig. 6 C, bottom). In con-
trast, coexpression of CaNA–YFP with myc–SAP97 in the
absence of AKAP79 resulted in cytoplasmic localization of
both proteins (Fig. 6 C, top). Under conditions where we
measured FRET between CaNA–CFP and PKA-RII–YFP
bound to AKAP79 (Fig. 5 C), we observed distinct targeting
of CaN, PKA, and SAP97 to overlapping plasma membrane
sites (Fig. 6 D, AKAP79 detected with Cy5 antibodies,
shown in monochrome). These data suggest that SAP97 can
be recruited to membranes/cortical cytoskeleton in associa-
Figure 6. Targeting of SAP97 to the CaN–AKAP79–PKA membrane cytoskeleton signaling complex. (A) AKAP79 regulates plasma membrane 
targeting of SAP97. SAP97–YFP (green) is primarily cytoplasmic when expressed alone ( AKAP79) but is targeted to the membrane ruffles in 
association with AKAP79–CFP ( AKAP79, blue) in live COS7 cells (CFP/YFP Overlay). (B) AKAP79 regulates targeting of SAP97 to the 
cortical membrane cytoskeleton through determinants that lie COOH terminal to the AKAP NH2-terminal targeting domain. SAP97–YFP 
(green) is targeted to the membrane ruffles enriched in F-actin (Texas red–phalloidin, red) in association with AKAP79–CFP (WT[1–427], top 
row, colocalization of SAP97, AKAP, and F-actin, seen as white in RGB composite panel). SAP97–YFP (green) is cytoplasmic when expressed 
with AKAP79(153)–CFP (blue) NH2-terminal domain, which targets to F-actin membrane ruffles (N[1–153], middle row, colocalization of 
(1–153) with F-actin, seen as pink in RGB composite panel) or an untargeted CFP–(150–427) AKAP79 fragment (C[150–427], bottom row). 
(C) AKAP79 regulates cortical colocalization of SAP97 with CaN in COS7 cells. CaNA–YFP (green) and myc–SAP97 (TxRd, red) are both 
cytoplasmic when expressed alone ( AKAP79) but are colocalized at the plasma membrane with each other and AKAP79–CFP (blue) in cells 
expressing all three proteins ( AKAP79), seen as white in the RGB composite. (D) AKAP79 coordinates targeting of CaN, PKA, and SAP97 to 
the same plasma membrane structures in COS7 cells. AKAP79 (anti-79, Cy5, monochrome) mediated membrane colocalization of CaNA–CFP 
(blue), PKA-RII–YFP (green), and myc–SAP97 (TxRd, red), seen as white in the RGB composite panel. Diagrams showing structures of the 
(E) AKAP79–CFP WT(1–427), N(1–153), and C(150–427) and (F) SAP97–YFP fusion proteins used above. Relevant cellular targeting, 
protein binding domains, and other structural motifs are indicated for both AKAP and SAP97 (see Results and Discussion for more details). 
Bars: (A and B)  15  m; (C and D)  20  m.T
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tion with the CaN–AKAP79–PKA ternary complex. Thus,
this macromolecular signaling complex is also likely to be as-
sembled endogenously on neuronal dendritic spines where it
could function in the regulation of glutamate receptor signal-
ing pathways underlying synaptic plasticity.
Discussion
FRET ratio methods with GFP variants have been used to
study cAMP-regulated binding between PKA catalytic (C)
and R subunits, PKA R subunit binding to untargeted
AKAP anchoring peptides, and phosphorylation of PKA
substrate indicators in living cells (Ruehr et al., 1999; Nagai
et al., 2000; Zaccolo et al., 2000; Zhang et al., 2001; Zac-
colo and Pozzan, 2002). However, FRET techniques have
not been used to image binding of PKA or other signaling
proteins to intact AKAP scaffolds at relevant subcellular lo-
cations as we have done here. Furthermore, we have
extended the use of FRET to observe, for the first time,
a ternary protein complex in living cells. Our FRET
measurements demonstrate that PKA-RII and CaNA are si-
multaneously bound within  50 Å of each other on a mem-
brane-targeted AKAP79 molecule. This important finding
significantly extends our understanding of the level of mo-
lecular compartmentalization of signaling proteins that is
made possible by scaffolding proteins. Recent intramolecu-
lar FRET studies with PKA–substrate indicators have ele-
gantly demonstrated that artificially tethering the substrate
and kinase in the same molecular complex allows very rapid
cAMP-stimulated phosphorylation (Zhang et al., 2001).
Our FRET observations of PKA and CaN anchored to-
gether on a nanometer scale nicely support proposed models
where AKAP79 organizes a signaling complex that facilitates
not only cAMP-stimulated phosphorylation but also effi-
cient Ca
2 -stimulated dephosphorylation of associated tar-
get substrates (Tavalin et al., 2002).
Evidence for the existence of complexes containing
AKAP79, PKA, CaN, and MAGUKs had previously been
obtained using immunoprecipitation and GST precipita-
tion with recombinant proteins and cell extracts (Coghlan
et al., 1995; Colledge et al., 2000; Gomez et al., 2002).
Due to the inherent limitations of precipitation reagents
and the use of cell extracts in these biochemical ap-
proaches, results from such studies may not always be en-
tirely representative of intact living cells. For instance, one
previous in vitro precipitation study suggested competition
between CaN and MAGUK binding to AKAP79 (Col-
ledge et al., 2000), whereas a second electrophysiological
study in live cells found no evidence for such competition
(Tavalin et al., 2002). Earlier attempts to map the CaN
binding site on AKAP79 using in vitro biochemical meth-
ods or the yeast two-hybrid system gave inconsistent results
and were only able to narrow the binding site to the
COOH-terminal two thirds of AKAP79 (Dell’Acqua et al.,
1998; Kashishian et al., 1998). In contrast, our more re-
cent studies combining cellular immunofluorescence with
in vitro biochemical assays were successful in mapping the
CaN anchoring site to a single 40-amino acid region in
very close proximity to the PKA anchoring site (Dell’Ac-
qua et al., 2002).
Thus, in order to get a more accurate view of AKAP79 scaf-
folding functions in vivo, we thought it was imperative to
study the formation of AKAP79 complexes in intact cells us-
ing not only immunofluorescence, which shows protein colo-
calization on a scale of 200 nm, but also FRET microscopy,
which detects true protein–protein proximity within 5 nm
(50 Å). Our current results show that by using micro-FRET,
we can directly visualize, on this 5-nm scale, binding of AKAP79
to CaNA and PKA-RII in a ternary complex at the plasma
membrane/cortical cytoskeleton of living cells. These binding
interactions were confirmed by measurement of FRET in
fixed cells using both micro-FRET and acceptor photobleach-
ing methods. Importantly, the CaN and PKA binding interac-
tions were shown to be through noncompeting sites near the
AKAP COOH terminus. FRET signal strength is a function
of not only the distance between chromophores but also the
binding affinity of the protein–protein interaction and chro-
mophore orientations within the complex. Thus, differences
in any of these parameters can explain the relative differences
in FRET signals between acceptor–donor pairs. For example,
the weaker FRETN
C that we measured for AKAP79–CaN
versus AKAP79–PKA binding could reflect both the 20–50-
fold weaker reported affinity of AKAP79 for CaNA versus RII
as well as the closer proximity of the PKA-RII binding site to
the AKAP COOH terminus (Fig. 1 C, 1; Carr et al., 1992;
Kashishian et al., 1998; Dell’Acqua et al., 2002). However,
consistent with chromophore separation contributing to our
observed differences in FRETN
C, when the CaN binding site
(321–360) is fused directly to CFP with no intervening se-
quence (Fig. 1 C, 4; Fig. 1 F, 2), larger CaNA–YFP FRETN
C
values (13.3 and 35.6) are measured than for full-length
AKAP79–CFP (2.8) (Table I). Extending this reasoning to
the CaN–AKAP–PKA complex is problematic because the
formation of a ternary complex is affected by the concentra-
tion of all three proteins and multiple binding affinities.
Nonetheless, stronger FRETN
C is seen for CaNA–CFP with
RII–YFP in the AKAP79 ternary complex (9.1) versus with
AKAP79–YFP in a binary complex (1.4) (Table I). This result
could be explained by the shorter distance between CaN and
RII bound to the AKAP compared with the distance between
CaN and the AKAP COOH terminus (Fig. 1 C, 1). It would
also follow from similar FRETN
C values (9.1 and 12.1) that
the distances between RII and CaN bound to AKAP79 may
be similar to the distance between bound RII and the
AKAP79 COOH terminus. Interestingly, the spacings be-
tween the CaN and PKA binding sites and the PKA binding
site and AKAP COOH terminus are in fact both 20–30
amino acids in primary sequence (Fig. 1 C, 1).
By combining CFP/YFP imaging with immunofluores-
cence, our current work also shows that AKAP79 can regu-
late the membrane cytoskeletal targeting of SAP97 in concert
with PKA and CaN and is not consistent with competition
between CaN and MAGUK binding. Thus, in neurons,
AKAP79 is likely to coordinate the assembly and targeting
of PKA–CaN–SAP97 complexes that are recruited to
the COOH terminus of AMPA-GluR1 receptors through
SAP97 PDZ domains (Fig. 6 F; Leonard et al., 1998). Re-
cently a great deal of attention in the field of hippocampal
synaptic plasticity has focused on regulation of the phosphor-
ylation state and localization of AMPA receptors throughT
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PKA and CaN pathways that are likely to be organized by
AKAP79–MAGUK scaffolding. NMDA receptor Ca
2  in-
flux in LTP, a synaptic strengthening process, leads to in-
creased AMPA receptor activity and phosphorylation (Lee et
al., 2000). In LTP, interactions of AMPA-GluR1 with
SAP97 PDZ domains (Fig. 6 F) and phosphorylation by
PKA may participate in both recruiting new receptors to the
postsynaptic membrane and increasing channel activity
(Banke et al., 2000; Hayashi et al., 2000; Passafaro et al.,
2001; Shi et al., 2001). In contrast, NMDA receptor activa-
tion in LTD, a weakening of synaptic strength, leads to de-
phosphorylation of the GluR1 PKA site and removal of
synaptic AMPA receptors by endocytosis through CaN
activation (Beattie et al., 2000; Ehlers, 2000; Lee et al.,
2000; Lin et al., 2000; Carroll et al., 2001). AKAP79 pro-
motes similar PKA and CaN regulation of SAP97-linked
AMPA-GluR1 receptors in heterologous systems and thus
could play an important role in organizing PKA and CaN
signals at synapses (Colledge et al., 2000; Dell’Acqua et al.,
2002; Tavalin et al., 2002). In support of this model, we
have recently shown that NMDA–CaN signaling pathways
controlling AMPA receptors also negatively regulate the lo-
calization and association of the endogenous AKAP79/150–
PKA complex with MAGUKs in neurons (Gomez et al.,
2002).
Localization of AKAP79/150 and AMPA receptors with
MAGUKs at synapses is dependent on the actin cytoskele-
ton, and, interestingly, both SAP97 and AMPA-GluR1 can
be linked to the cytoskeleton through 4.1 actin binding
proteins (Lue et al., 1994; Shen et al., 2000; Zhou et al.,
2001; Gomez et al., 2002). However, targeting of SAP97 to
cortical actin in epithelial cells depends on an NH2-termi-
nal domain (SAP97[1–65]) not present in other MAGUKs
as well as secondarily on 4.1 binding (Fig. 6 E; Reuver and
Garner, 1998; Wu et al., 1998). Thus, it has been proposed
that common binding of SAP97 and GluR1 to 4.1 and ac-
tin may stabilize AMPA receptors at synapses. However,
our findings show that AKAP79 can also regulate targeting
of SAP97 to membrane cytoskeleton structures. Thus, the
association of AKAP79 with SAP97 may be an additional
targeting signal for both proteins that provides AKAP–
SAP97–AMPA receptor complexes further attachment to
the postsynaptic cytoskeleton.
As discussed above, the molecular compartmentalization
of CaN and PKA in the AKAP79 complex and how they re-
spond to cAMP and Ca
2  signals is likely to be very impor-
tant for efficient bidirectional regulation of AMPA receptor
phosphorylation and trafficking. AKAP79 binding to CaN
inhibits phosphatase activity in vitro even with CaNB and
Ca
2 -calmodulin activators present (Coghlan et al., 1995;
Dell’Acqua et al., 2002). In contrast, AKAP79 targets ba-
sally active PKA holoenzyme that can be further activated by
elevated cAMP through increased C subunit release; how-
ever, it is unknown whether the inhibitory CaNA binding to
AKAP79 is regulated by synaptic Ca
2  signals that activate
CaN. Future applications of FRET imaging methods in
transfected neurons will allow us to examine the regulation
of CaN–AKAP79–PKA binding interactions and targeting
by neuronal Ca
2  signaling pathways involved in synaptic
plasticity.
Materials and methods
Construction of cDNA expression plasmids
The cDNAs for human AKAP79 wild type (WT),  PKA (1–361), and
 CaN ( 315–360) mutants were expressed from pCDNA3 (Invitrogen) as
previously described (Dell’Acqua et al., 1998, 2002). The coding se-
quences for AKAP79WT, (1–153),  PKA(1–361),   CaN( 315–360), or
the 321–360 CaN binding fragment were subcloned into pEGFPN1
(CLONTECH Laboratories, Inc.) as previously described (Dell’Acqua et
al., 1998, 2002). CFP and YFP variants of these fusion proteins were gen-
erated by exchange of GFP using BamHI-–NotI fragments from pECFPN1
or pEYFPN1 (constructed by PCR with ECFP and EYFP from pRSET into
pEGFPN1, 2, or 3). CFP–AKAP79(150–427) in pECFPC2 was constructed
as previously described (Gomez et al., 2002). pEGFPN2-AKAP18(1–16)
was constructed as previously described (Trotter et al., 1999), and
ECFP  and EYFP variants were generated by BamHI–NotI exchange.
AKAP79(321–360)–CFP was fused onto the COOH terminus of the
AKAP18(1–16) sequence as a BglII–NotI PCR product into BamHI–
NotI-digested AKAP18(1–16) vector to generate the AKAP18(1–16)–
AKAP79(321–360)–ECFP fusion. Construction of mouse CaNA  sub-
unit  tagged with myc (9E10) epitope on its COOH terminus in
pCDNA3.1MycHis( )A (Invitrogen) was previously described (Dell’Ac-
qua et al., 2002). CaNA was transferred from this vector as a HindIII–
EcoRI fragment into pECFPN2 or pEYFPN2. The mouse PKA-RII  coding
sequence was subcloned into pEGFPN3 as previously described (Gomez
et al., 2002), and ECFP and EYFP versions were obtained by BamHI–NotI
exchange. The myc–SAP97 expression plasmid was provided by Marcie
Colledge (Oregon Health and Science University, Portland, OR) and Mor-
gan Sheng (Massachusetts Institute of Technology, Cambridge, MA). The
SAP97 coding sequence was amplified with a 5  T7 promoter primer and
a 3  sequence-specific primer with an EcoRI restriction site. The SAP97
PCR product was cloned as a BglII–EcoRI fragment into pEYFPN2.
COS7 cell culture and transfection
COS7 cells at 20–50% confluency (24–48 h after plating on glass cover-
slips in six-well plates) were transfected by calcium phosphate precipita-
tion with cDNA expression constructs (0.5–2  g each plasmid) for 4–16 h
at 5% CO2, 37 C. Cells were washed twice with PBS, fed with DME, 10%
FBS, and 1% penicillin/streptomycin (Invitrogen; GIBCO BRL), and grown
for 24–48 h before live cell imaging or fixation for immunocytochemistry.
Immunocytochemistry and digital fluorescence microscopy
COS7 cells were washed in PBS, fixed in 3.7% formaldehyde/PBS, and
permeabilized in 0.2% Triton X-100/PBS. For staining of myc–CaNA,
myc–SAP97, or AKAP79, cells were blocked in PBS   3.0% BSA for 30
min, followed by incubation with primary antibodies (1:250 anti-myc
[9E10] [Santa Cruz] or 1:1,000 anti-AKAP79 [918I] [Icos]) for 1 h, fol-
lowed by washing in PBS. Next, coverslips were incubated for 1 h with
secondary antibodies (goat anti-mouse–Texas red, goat anti-rabbit–Texas
red, or goat anti-rabbit–Cy5 [Molecular Probes or Amersham Biosciences])
and, in some cases, 1:500 Texas red–phalloidin (Molecular Probes) fol-
lowed by washing in PBS. Coverslips were mounted on glass slides using
the Pro-long anti-fade (Molecular Probes). Specific indirect immunofluo-
rescence and/or intrinsic CFP and YFP fluorescence was detected with
chroma filter sets using a Nikon TE-300 inverted microscope (100 plan-
apo, oil, 1.4 NA) with Micromax (Princeton Instruments) or Sensicam
(Cooke) digital CCD cameras and Slidebook 3.0 software (Intelligent Imag-
ing Innovations). All images (including FRET images, see below) were ex-
ported from Slidebook in Tiff RGB format and figures assembled using
Adobe Photoshop 5.5
®.
CFP/YFP FRET microscopy and image analysis
For CYFRET imaging experiments in living cells, COS7 cells were trans-
fected on 25-mm round glass coverslips and, 24–48 h later, placed in an
imaging chamber (Molecular Probes) at room temperature in media on the
stage of the microscope described above. CYFRET image acquisition and
analysis were done by the three-filter “micro-FRET” image subtraction
method described by Sorkin et al. (2000). In brief, three images (100-ms or
250-ms exposure sets, 2   2 binning) were obtained: a YFP excitation/YFP
emission image; a CFP excitation/CFP emission image; and a CFP excita-
tion/YFP emission image (raw, uncorrected CYFRET). After imaging, back-
ground images were taken. Background-subtracted YFP and CFP images
were then fractionally subtracted from raw CYFRET images based on mea-
surements for CFP bleedthrough (0.50–0.56) and YFP cross-excitation
(0.015–0.02). This fractional subtraction generated corrected FRET
C im-
ages, represented in monochrome or pseudo-color (gated to YFP acceptorT
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levels), showing sensitized FRET within cells. The subtraction coefficients
are rounded up from average cross-bleed values determined in cells ex-
pressing CFP- or YFP-tagged constructs alone. Thus, these coefficients re-
sult in the underestimation of FRET
C signals for true FRET partners but pre-
vent false positive detection of FRET.
Independent YFP acceptor photobleaching FRET measurement of CFP
donor quenching was performed in fixed cells mounted without anti-fade
reagent. YFP was selectively bleached by excitation at 535 nM for 2 min.
The prebleach CFP image was then subtracted from the post-bleach CFP
image to generate a pseudo-color image showing CFP quenching ( CFP)
due to FRET (gated to post-bleach CFP levels). Calculation of CFP quench-
ing apparent FRET efficiency values from the photobleaching method and
normalized FRETN
C values from the micro-FRET method used Slidebook
mask analysis. CFP quenching apparent FRET efficiency values were ob-
tained by dividing the mean intensity for change in CFP fluorescence after
YFP photobleaching by the post-bleach CFP mean intensity (CFPpostbleach  
CFPprebleach      CFP/CFPpostbleach) for masks covering entire cells. Values
from multiple cells were averaged to give the mean apparent FRET effi-
ciency expressed as a percentage   SEM. FRET
C intensity values were ob-
tained by fractional subtraction (using coefficients described above) of
mean intensities for CFP and YFP from raw CYFRET for masks covering
membrane ruffles and vesicles. FRET
C was converted to FRETN
C by divid-
ing with the product of CFP and YFP intensities (FRETN
C   FRET
C/CFP  
YFP). FRETN
C values were averaged for multiple cells to generate mean
FRETN
C values   SEM ( 10
 5) (Table I). Negative FRETN
C values are ob-
tained when there is no FRET due to the overcorrection for CFP and YFP
cross-bleeding. FRETN
C is proportional to the equilibrium constant for the
binding interaction (Gordon et al., 1998; Sorkin et al., 2000).
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